Enovis ENOV
NYSE ENOV
$26.06 -0.12 (-0.46%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011)

Enovis (ENOV) posted quarterly Non-Current Deferred Tax Liability of $13.1 million for Q4 2011, down 2.84% year-over-year from $13.5 million in Q4 2010, and down 17.47% quarter-over-quarter from $15.9 million in Q3 2011.

Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011) Analysis & Trends

Enovis (ENOV) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $13.1 million the latest figure, recorded in Q4 2011.

  • In Q4 2011, Non-Current Deferred Tax Liability fell 2.84% year-over-year to $13.1 million; the TTM figure through Dec 2011 stood at $13.1 million (down 2.84% YoY), while the FY2011 annual figure was $13.1 million, down 2.84% from the prior year.
  • Non-Current Deferred Tax Liability declined to $13.1 million in Q4 2011 per ENOV's latest filing, from $15.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $16.7 million in Q3 2011 and bottomed at $13.1 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Enovis 1.51 Bn 1.50 Bn 359.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 13.15 Mn
Dec 31, 2011 13.15 Mn
Sep 30, 2011 15.93 Mn
Sep 30, 2011 15.93 Mn
Jul 1, 2011 16.71 Mn
Jul 1, 2011 16.71 Mn
Dec 31, 2010 13.53 Mn
Dec 31, 2010 13.53 Mn